Medicine and Dentistry
Analysis
5%
Arm
9%
Cost-Effectiveness Analysis
9%
Crohn's Disease
63%
Faecal Calprotectin
63%
Gene
11%
Marker
5%
Medical Care
45%
Medically Unexplained Physical Symptoms
9%
Mood
9%
Patient
75%
Patient Health Questionnaire 15
18%
Patient Health Questionnaire 9
9%
Patient with Crohn's Disease
5%
Randomized Controlled Trial
63%
Retrospective Study
5%
Secondary Care
63%
Sensitivity and Specificity
5%
Social Adaptation
27%
Spontaneous Remission
17%
Symptom
63%
Syndrome
9%
Therapeutic Procedure
100%
Biochemistry, Genetics and Molecular Biology
BTNL2
63%
Exon
15%
Gene
74%
Genotyping
15%
Immune-Related Gene
63%
Major Histocompatibility Complex
15%
S100A9
5%
Sequencing
63%
Nursing and Health Professions
Behavioral Intervention
27%
Cost Effectiveness Analysis
9%
Medically Unexplained Symptom
9%
Randomization
9%
Secondary Health Care
63%
Standard
36%
